Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is the world’s leading healthcare diagnostics company, providing comprehensive clinical laboratory services through LabCorp Diagnostics, and end-to-end drug development support through Covance Drug Development. LabCorp is a pioneer in commercializing new diagnostic technologies and is improving people’s health by delivering the combination of world-class diagnostics, drug development and knowledge services. With combined revenue pro... More >>

Recent NewsMore >>
08/23/16LabCorp’s Acquisition of Sequenom Clears Antitrust Review
BURLINGTON, N.C.--(BUSINESS WIRE)--Aug. 23, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act, applicable to the acquisition of Sequenom, Inc. (“Sequenom”) by LabCorp has expired. As previously announced, LabCorp and Savoy Acquisition Corp., its direct wholly owned subsidiary (“Purchaser”), commenced a tender off... 
Printer Friendly Version
08/09/16LabCorp Commences Cash Tender Offer for All Outstanding Shares of Sequenom, Inc.
BURLINGTON, N.C.--(BUSINESS WIRE)--Aug. 9, 2016-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Sequenom, Inc. (NASDAQ: SQNM) for $2.40 per share. The tender offer is being made by Savoy Acquisition Corp., a wholly owned subsidiary of LabCorp, pursuant to an offer to purchase, dated August 9, 2016. LabCorp and Sequenom previously announced... 
Printer Friendly Version
08/02/16LabCorp Announces the Availability of the CDC Zika MAC-ELISA Test
The CDC Zika MAC-ELISA Test Has Received FDA Emergency Use Authorization and Complements the RealStar® Zika Virus RT-PCR Kit U.S. BURLINGTON, N.C.--(BUSINESS WIRE)--Aug. 2, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) today announced the nationwide availability of testing for Zika virus using the Zika Immunoglobulin M (IgM) Antibody Capture Enzyme-Linked Immunosorbent Assay (Zika MAC-ELISA) developed by the Ce... 
Printer Friendly Version
07/27/16LabCorp Announces Agreement to Acquire Sequenom
Acquisition Creates Market Leader in NIPT, Women’s Health and Reproductive Genetics LabCorp CEO: ‘This is exactly the kind of strategic acquisition that LabCorp seeks’ BURLINGTON, N.C. & SAN DIEGO--(BUSINESS WIRE)--Jul. 27, 2016-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH), the world’s leading healthcare diagnostics company, and Sequenom, Inc. (NASDAQ:SQNM), a pioneer in non-invasive prenatal testing (N... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
Change Stock is Up 0.62
Intraday High$137.23
Intraday Low$135.21
Data as of 08/26/16
4:02 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2015 Annual Report

2014 Annual Report

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release